Your AI Says Premium. The Buyer’s AI Says Discount. Neither Answer Is the Market.
This is a guest post from Max Friar, Founder and Managing Partner of Calder Capital, an Axial member since 2015…
The Middle Market Review Insights on the Middle Market.
Thanks for subscribing!
Surprise, the frictionless economy is here. Is your company ready for the future, or still stuck in the 20th century?
Business Insights
- This company has never had layoffs
- Welcome to the friction-free economy
- How “stay interviews” help retain employees
- Don’t be like VW
- High-growth small businesses are key to economic growth
Transaction Toolbox
- How to deal with a tough reorg
- Growth in manufacturing M&A predicted to slow down
Forum Features
- Should you leave your company to your daughter?
- Things to think about before you sell your business
- The outlook for industrials and manufacturing M&A
Middle Market Move of the Week
NeoGenomics, a clinical lab specializing in cancer genetics diagnostic testing, announced it would acquire Clarient Inc., a cancer diagnostic testing firm and GE subsidiary. The Wall Street Journal reports that the deal is potentially valued at 275.2 million.
Learn More About Joining Axial
Related Content
Subscribe to Middle Market Review
